Most Read Articles
6 days ago

Dr Michael Lim, a senior consultant at the Paediatric Pulmonary and Sleep Division, National University Hospital, Singapore, speaks to Roshini Claire Anthony on the rare disease that is cystic fibrosis.

4 days ago
Susceptibility‐guided therapy is as effective as empiric modified bismuth quadruple therapy for the first-line treatment of Helicobacter pylori infection, with both yielding excellent eradication rates, as shown in a recent trial.
6 days ago
It appears that long-term consumption of fish and omega-3 fatty acid does not influence the risk of incident hypertension in middle-aged and older men, suggests a US study.
2 days ago
Cabozantinib is not better than mitoxantrone-prednisone at relieving pain in patients with metastatic castration-resistant prostate cancer (mCRPC) with symptomatic bone metastasis, a recent study suggests.

Combination therapy plus IPP insertion safe, effective in patients with Peyronie’s disease

09 Sep 2018

A combined approach of intraoperative and postoperative therapies as well as an inflatable penile prosthesis (IPP) in the treatment of Peyronie’s disease has been shown to be safe and effective with excellent functional outcomes, according to a study. Additionally, penile curvature corrections are statistically significant, while complications are negligible.

Endocavernous disruption of Peyronie’s disease plaques via the scratch technique was conducted in 145 patients, followed by IPP insertion. Patients were then postoperatively assigned to vacuum device therapy for 3 minutes twice daily to continue penile curvature correction. Follow-up lasted for 1 year after surgery. The authors then assessed anatomical and functional results.

Mean postoperative residual curvature was 21.5±4.5, 17.3±4.8 and 14.1±3.1 degrees among patients with plaques in the proximal third, middle third and subcoronal areas of the penis, respectively. Mean penile curvature deviation after 24 weeks of vacuum therapy decreased to 8.7±2.5, 9.1±2.9 and 7.7±0.9 degrees, respectively.

The corresponding mean IIEF-5 (International Index of Erectile Function) scores preoperatively, at 6 months (p<0.001) and at 1 year (p<0.001) were 9.8±2.3, 18.9±3.1 and 24.1±3.6. At the end of follow-up, mean EDITS (Erectile Dysfunction Inventory of Treatment Satisfaction) score was 64.6±11.8. Moreover, there were minimal operative and postoperative complications.

A study by Chung and colleagues has shown that insertion of IPP with synchronous penile plication for the correction of erectile dysfunction and Peyronie’s disease is effective and leads to high patient satisfaction. [J Sex Med 2014;11:1593-1598]

“Peyronie’s disease is a devastating condition resulting in penile malformation, erectile dysfunction, pain and emotional distress,” the authors noted.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
6 days ago

Dr Michael Lim, a senior consultant at the Paediatric Pulmonary and Sleep Division, National University Hospital, Singapore, speaks to Roshini Claire Anthony on the rare disease that is cystic fibrosis.

4 days ago
Susceptibility‐guided therapy is as effective as empiric modified bismuth quadruple therapy for the first-line treatment of Helicobacter pylori infection, with both yielding excellent eradication rates, as shown in a recent trial.
6 days ago
It appears that long-term consumption of fish and omega-3 fatty acid does not influence the risk of incident hypertension in middle-aged and older men, suggests a US study.
2 days ago
Cabozantinib is not better than mitoxantrone-prednisone at relieving pain in patients with metastatic castration-resistant prostate cancer (mCRPC) with symptomatic bone metastasis, a recent study suggests.